Colorado Serum Company Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Industry

Employee Data

  • Colorado Serum Company has 40 Employees.(i)
  • Colorado Serum Company grew their employee count by 5% last year.

Continuing its long and distinguished history of manufacturing quality and effective biologicals, Colorado Serum Company created a subsidiary in 1957 - named Professional Biological Company - with the purpose of servicing the growing needs and demands of licensed veterinarians. Colorado Serum Company started in the early 1900’s when Hog Cholera disease was decimating the swine industry in the United States. Dr. J.N. Huff, a graduate of the Kansas City Veterinary College, moved to Denver, CO in 1922 to open a satellite manufacturing plant to the original "American Serum Company" founded in Sioux City, IA. Denver’s high altitude provided hogs with enriched blood, so Colorado was considered an ideal environment for producing a new antiserum for Hog Cholera. In 1923, the small Denver plant began production and shortly thereafter separated from American Serum to become Colorado Serum Company. Hog Cholera was eventually eradicated from the United States.

keywords:N/A

N/A

Total Funding

40

Number of Employees

N/A

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Colorado Serum Company News

2022-04-17 - Anthrax Vaccines Market Size And Forecast | Zoetis Inc ...

Zoetis Inc., Emergent Bio-Solutions, Merck & Co. Inc., Colorado Serum, PharmaAthene Inc., Vecol, Biogenesis Bago Inc., Porton Biopharma Inc.,...

2022-04-13 - Insights on the Brucellosis Vaccine Global Market to 2031 ...

Merck Animal Health; Ceva Sante Animale; CZ Vaccines; Colorado Serum Company; Indian Immunologicals Ltd. Hester Biosciences Limited...

2022-04-06 - Animal Vaccines Market Revenue Growth, Qualitative ...

... PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M40-39%N/A
#2
$4.6M405%N/A
#3
$7.3M4014%N/A
#4
$3.5M4038%N/A
#5
$8.6M40-34%$18.2M